These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22927020)

  • 41. Clinical effect of meso-tetrahydroxyphenylchlorine based photodynamic therapy in recurrent carcinoma of the ovary: preliminary results.
    Wierrani F; Fiedler D; Grin W; Henry M; Dienes E; Gharehbaghi K; Krammer B; Grünberger W
    Br J Obstet Gynaecol; 1997 Mar; 104(3):376-8. PubMed ID: 9091020
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Randomised controlled trial of temoporfin photodynamic therapy plus chemotherapy in nonresectable biliary carcinoma--PCS Nordic study.
    Hauge T; Hauge PW; Warloe T; Drolsum A; Johansen C; Viktil E; Aabakken L; Buanes T; Konopski Z
    Photodiagnosis Photodyn Ther; 2016 Mar; 13():330-333. PubMed ID: 26415549
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term follow-up in patients treated with curative electrochemotherapy for cancer in the oral cavity and oropharynx.
    Landström FJ; Reizenstein J; Adamsson GB; Beckerath Mv; Möller C
    Acta Otolaryngol; 2015; 135(10):1070-8. PubMed ID: 26061895
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The prognostic impact of metastatic pattern of lymph nodes in patients with oral and oropharyngeal squamous cell carcinomas.
    Wenzel S; Sagowski C; Kehrl W; Metternich FU
    Eur Arch Otorhinolaryngol; 2004 May; 261(5):270-5. PubMed ID: 14504863
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Photodynamic therapy using meta-tetrahydroxyphenylchlorin (Foscan) for the treatment of vulval intraepithelial neoplasia.
    Campbell SM; Gould DJ; Salter L; Clifford T; Curnow A
    Br J Dermatol; 2004 Nov; 151(5):1076-80. PubMed ID: 15541088
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Simultaneous squamous cell carcinomas of the oral cavity and oropharynx].
    Ricard AS; Majoufre-Lefebvre C; Demeaux H; Siberchicot F; Zwetyenga N
    Rev Stomatol Chir Maxillofac; 2007 Dec; 108(6):509-12. PubMed ID: 17881023
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic factors in salvage surgery for recurrent oral and oropharyngeal cancer.
    Agra IM; Carvalho AL; Ulbrich FS; de Campos OD; Martins EP; Magrin J; Kowalski LP
    Head Neck; 2006 Feb; 28(2):107-13. PubMed ID: 16388526
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic significance of computed tomography in tumors of the oral cavity and oropharynx treated with neoadjuvant chemotherapy.
    Verschuur HP; Marcy PY; Granon C; Bensadoun RJ; Dassonville O; Schneider M; Demard F
    Am J Otolaryngol; 1997; 18(3):190-6. PubMed ID: 9164622
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adjuvant low single dose cisplatin-based concurrent radiochemotherapy of oral cavity and oropharynx carcinoma: impact of extracapsular nodal spread on distant metastases.
    Kuhnt T; Klockenbrink U; Knipping S; Lautermann J; Kriese K; Wienke A; Hildebrandt G; Hauptmann S
    Strahlenther Onkol; 2011 May; 187(5):292-9. PubMed ID: 21533760
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intra-arterial high-dose chemotherapy with cisplatin as part of a palliative treatment concept in oral cancer.
    Rohde S; Kovács AF; Turowski B; Yan B; Zanella F; Berkefeld J
    AJNR Am J Neuroradiol; 2005 Aug; 26(7):1804-9. PubMed ID: 16091533
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical experiences with photodynamic therapy for recurrent malignancies of the lower female genital tract.
    Lobraico RV; Grossweiner LI
    J Gynecol Surg; 1993; 9(1):29-34. PubMed ID: 10148524
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interventions for the treatment of oral and oropharyngeal cancers: surgical treatment.
    Bessell A; Glenny AM; Furness S; Clarkson JE; Oliver R; Conway DI; Macluskey M; Pavitt S; Sloan P; Worthington HV
    Cochrane Database Syst Rev; 2011 Sep; (9):CD006205. PubMed ID: 21901703
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Photodynamic Therapy as an Alternative Therapeutic Tool in Functionally Inoperable Oral and Oropharyngeal Carcinoma: A Single Tertiary Center Retrospective Cohort Analysis.
    Lambert A; Nees L; Nuyts S; Clement P; Meulemans J; Delaere P; Vander Poorten V
    Front Oncol; 2021; 11():626394. PubMed ID: 33747943
    [No Abstract]   [Full Text] [Related]  

  • 54. [Photodynamic therapy by coloring laser. Can it represent a therapeutic alternative for small epidermoid cancers of the esophagus?].
    Hochain P; Ducrotté P; Paillot B; Touchais JY; Thorel JM; Petit A; Ouvry D; Hecketsweiler P
    Gastroenterol Clin Biol; 1992; 16(6-7):552-7. PubMed ID: 1526417
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Foscan-based photodynamic treatment in vivo: correlation between efficacy and Foscan accumulation in tumor, plasma and leukocytes.
    Maugain E; Sasnouski S; Zorin V; Merlin JL; Guillemin F; Bezdetnaya L
    Oncol Rep; 2004 Sep; 12(3):639-45. PubMed ID: 15289849
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Photodynamic therapy in the treatment of multiple primary tumours in the head and neck, located to the oral cavity and oropharynx.
    Copper MP; Triesscheijn M; Tan IB; Ruevekamp MC; Stewart FA
    Clin Otolaryngol; 2007 Jun; 32(3):185-9. PubMed ID: 17550506
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [BCG versus photodynamic therapy (PDT) for nonmuscle invasive bladder cancer-a multicentre clinical phase III study].
    Jocham D; von Wietersheim J; Pflüger H; Steiner H; Doehn C; Büttner H; Böhle A; Kausch I
    Aktuelle Urol; 2009 Mar; 40(2):91-9. PubMed ID: 19214951
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is surgery necessary in stage III and stage IV cancer of the head and neck that responds to induction chemotherapy?
    Poulsen M; Aldren C; Tripcony L; Walker Q
    Arch Otolaryngol Head Neck Surg; 1996 May; 122(5):467-71. PubMed ID: 8615961
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Survival evaluation of treatment modality in squamous cell carcinoma of the oral cavity and oropharynx.
    Pericot J; Escribà JM; Valdés A; Biosca MJ; Monner A; Castellsagué X; Galiana R; Piulachs P; Escutia E; Mari A
    J Craniomaxillofac Surg; 2000 Feb; 28(1):49-55. PubMed ID: 10851674
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic staging system for recurrent, persistent, and second primary cancers of the oral cavity and oropharynx.
    Yueh B; Feinstein AR; Weaver EM; Sasaki CT; Concato J
    Arch Otolaryngol Head Neck Surg; 1998 Sep; 124(9):975-81. PubMed ID: 9738805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.